A Multicenter Assessment of ALD403 in Frequent Episodic Migraine

NCT02559895 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

898

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Disorders

Interventions

DRUG: ALD403
DRUG: Placebo

Sponsor

Alder Biopharmaceuticals, Inc.